This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Wim Schepens
Introduction
Wim Schepens is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate the STING pathway. His work is crucial for advancing treatments for various diseases and disorders.
Latest Patents
Wim Schepens holds a patent for "Cyclic dinucleotides as sting agonists." This patent discloses compounds, compositions, and methods for treating diseases, syndromes, or disorders that are affected by the modulation of STING. The compounds are represented by a specific formula, where various components are defined in detail.
Career Highlights
Schepens is currently employed at Janssen Biotech, Inc., a leading company in the pharmaceutical industry. His role involves research and development aimed at creating innovative solutions for healthcare challenges. His expertise in the field has positioned him as a valuable asset to his team.
Collaborations
Wim Schepens has collaborated with notable colleagues, including Stuart Emanuel and Mark Richter. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Wim Schepens exemplifies the spirit of innovation in biotechnology through his patent and contributions at Janssen Biotech, Inc. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile